{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:05:35Z","timestamp":1774008335735,"version":"3.50.1"},"reference-count":28,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2020,2,25]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>von Willebrand factor (vWF) has prognostic value in patients with heart failure (HF) and in those with liver disease. Liver congestion, due to right-sided HF (RHF), is one of the major clinical pathophysiologic manifestations in adults with congenital heart disease (ACHD). The present study\u2019s purpose was to clarify the prognostic value of plasma levels of vWF antigen (vWF:Ag) in ACHD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We measured vWF:Ag (%) in 382 consecutive patients (20 unrepaired cyanotic ACHD, 172 Fontan patients and 190 ACHD after biventricular repair) and compared the results with the clinical profiles and prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The plasma vWF:Ag level was 130\u00b153 (normal range: 55%\u2013190%), and 48 patients (13%) showed high levels of vWF:Ag (\u2265190%). Older age, Fontan circulation, higher central venous pressure, lower arterial oxygen saturation and lower plasma levels of albumin were independently associated with high log (vWF:Ag) (p&lt;0.05\u20130.0001). During the follow-up of 2.4\u00b11.4 years, 15 patients died. High log (vWF:Ag) predicted the all-cause mortality (HR 1.63 per 0.1, 95% CI 1.40 to 1.96, p&lt;0.0001). Specifically, patients with high vWF:Ag (\u2265165%) had a substantially higher risk of all-cause mortality (HR 56.4, 95%\u2009CI 11.4 to 1020, p&lt;0.0001), and this prognostic value was independent of plasma levels of brain-type natriuretic peptide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High vWF:Ag may reflect RHF severity and related liver dysfunction with a strong prognostic value of all-cause mortality in ACHD. Thus, vWF:Ag might be an excellent biomarker for monitoring ACHD with RHF.<\/jats:p><\/jats:sec>","DOI":"10.1136\/heartjnl-2019-316007","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T21:15:36Z","timestamp":1584566136000},"page":"910-915","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic value of von Willebrand factor in adult patients with congenital heart disease"],"prefix":"10.1136","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-4792","authenticated-orcid":false,"given":"Hideo","family":"Ohuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohsuke","family":"Hayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikari","family":"Miike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-9130","authenticated-orcid":false,"given":"Toru","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Konagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heima","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michikazu","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"2024111103150938000_106.12.910.1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12008"},{"key":"2024111103150938000_106.12.910.2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1160\/TH09-01-0036","article-title":"Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure","volume":"102","author":"Gombos","year":"2009","journal-title":"Thromb Haemost"},{"key":"2024111103150938000_106.12.910.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001478"},{"key":"2024111103150938000_106.12.910.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.12.033"},{"key":"2024111103150938000_106.12.910.5","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/2050640618779660","article-title":"Von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C","volume":"6","author":"Takaya","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"2024111103150938000_106.12.910.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25806"},{"key":"2024111103150938000_106.12.910.7","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.14522","article-title":"Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity","volume":"47","author":"Mandorfer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2024111103150938000_106.12.910.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000560"},{"key":"2024111103150938000_106.12.910.9","doi-asserted-by":"crossref","unstructured":"Rychik J , Atz AM , Celermajer DS , et al . Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American heart association. Circulation 2019:CIR0000000000000696.doi:10.1161\/CIR.0000000000000696","DOI":"10.1161\/CIR.0000000000000696"},{"key":"2024111103150938000_106.12.910.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.011241"},{"key":"2024111103150938000_106.12.910.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.04.070"},{"key":"2024111103150938000_106.12.910.12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2257.2000.00281.x","article-title":"Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STa Liatest vWF) automated on the MDA 180 coagulometer","volume":"22","author":"Sukhu","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"2024111103150938000_106.12.910.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01949.x"},{"key":"2024111103150938000_106.12.910.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00803-1"},{"key":"2024111103150938000_106.12.910.15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004133","article-title":"Heart failure, left ventricular remodeling, and circulating nitric oxide metabolites","volume":"5","author":"Chirinos","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2024111103150938000_106.12.910.16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ehf2.12319","article-title":"Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure","volume":"5","author":"Chirinos","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2024111103150938000_106.12.910.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.24.2709"},{"key":"2024111103150938000_106.12.910.18","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153349.77489.CF"},{"key":"2024111103150938000_106.12.910.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.534073"},{"key":"2024111103150938000_106.12.910.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.4.2355"},{"key":"2024111103150938000_106.12.910.21","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.301359"},{"key":"2024111103150938000_106.12.910.22","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12564"},{"key":"2024111103150938000_106.12.910.23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/hep.29651","article-title":"Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection","volume":"67","author":"Starlinger","year":"2018","journal-title":"Hepatology"},{"key":"2024111103150938000_106.12.910.24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230613"},{"key":"2024111103150938000_106.12.910.25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23918"},{"key":"2024111103150938000_106.12.910.26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjcard.2015.11.014","article-title":"Liver disease in patients after the Fontan operation","volume":"117","author":"Pundi","year":"2016","journal-title":"Am J Cardiol"},{"key":"2024111103150938000_106.12.910.27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.117.032717","article-title":"Hepatocellular carcinoma after Fontan operation","volume":"138","author":"Egbe","year":"2018","journal-title":"Circulation"},{"key":"2024111103150938000_106.12.910.28","first-page":"E139","article-title":"Hepatocellular carcinoma in an adult with repaired tetralogy of Fallot","volume":"8","author":"McCabe","year":"2013","journal-title":"Congenit Heart Dis"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-316007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:16:22Z","timestamp":1731323782000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-316007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,5,27]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/heartjnl-2019-316007"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-316007","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]}}}